Antineoplastic agents

Description:

Supply of medicinal products

Delivery of medicinal products in accordance with the provisions of the Terms of Use and the price form

Ramucirumabum

Group 1 - RAMUCIRUMABUM. In accordance with the provisions of the Terms of Use and the Pricing Form

Paclitaxelum albuminatum

Group 10 - PACLITAXELUM ALBUMINATUM. In accordance with the provisions of the Terms of Use and the pricing form.

Sacituzumabum govitecanum

Group 11 - SACITUZUMABUM GOVITECANUM. In accordance with the provisions of the Terms of Use and the pricing form.

Lenalidomidum

Group 12 - LENALIDOMIDUM. In accordance with the provisions of the Terms of Use and the pricing form.

Apalutamidum

Group 2 - APALUTAMIDUM. In accordance with the provisions of the Terms of Use and the Pricing Form

Durvalumabum

Group 3 - DURVALUMABUM. In accordance with the provisions of the Terms of Use and the pricing form.

Regorafenibum

Group 4 - REGORAFENIBUM. In accordance with the provisions of the Terms of Use and the pricing form.

Peginterferonum alpha-2a

Group 5 - PEGINTERFERONUM ALFA-2a. In accordance with the provisions of the Terms of Use and the pricing form.

CEMIPLIMABUM

Group 6 - CEMIPLIMABUM. In accordance with the provisions of the Terms of Use and the pricing form.

Pegfilgrastimum

Group 7 - PEGFILGRASTIMUM. In accordance with the provisions of the Terms of Use and the pricing form.

Rituximabum

Group 8 - RITUXIMABUM. In accordance with the provisions of the Terms of Use and the pricing form.

Trabectedinum

Group 9 - TRABECTEDINUM. In accordance with the provisions of the Terms of Use and the pricing form.